306 related articles for article (PubMed ID: 29018224)
1. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.
Woo HG; Choi JH; Yoon S; Jee BA; Cho EJ; Lee JH; Yu SJ; Yoon JH; Yi NJ; Lee KW; Suh KS; Kim YJ
Nat Commun; 2017 Oct; 8(1):839. PubMed ID: 29018224
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
[TBL] [Abstract][Full Text] [Related]
4. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
Kwon SM; Kim DS; Won NH; Park SJ; Chwae YJ; Kang HC; Lee SH; Baik EJ; Thorgeirsson SS; Woo HG
Carcinogenesis; 2013 Jul; 34(7):1543-50. PubMed ID: 23508637
[TBL] [Abstract][Full Text] [Related]
5. Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.
Shen J; LeFave C; Sirosh I; Siegel AB; Tycko B; Santella RM
BMC Med Genomics; 2015 Jun; 8():28. PubMed ID: 26059414
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.
Jee BA; Choi JH; Rhee H; Yoon S; Kwon SM; Nahm JH; Yoo JE; Jeon Y; Choi GH; Woo HG; Park YN
Cancer Res; 2019 Nov; 79(21):5500-5512. PubMed ID: 31506333
[TBL] [Abstract][Full Text] [Related]
7. Single-cell triple omics sequencing reveals genetic, epigenetic, and transcriptomic heterogeneity in hepatocellular carcinomas.
Hou Y; Guo H; Cao C; Li X; Hu B; Zhu P; Wu X; Wen L; Tang F; Huang Y; Peng J
Cell Res; 2016 Mar; 26(3):304-19. PubMed ID: 26902283
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.
Yang L; Zhang Z; Sun Y; Pang S; Yao Q; Lin P; Cheng J; Li J; Ding G; Hui L; Li Y; Li H
Aging (Albany NY); 2020 Nov; 12(23):23849-23871. PubMed ID: 33221766
[TBL] [Abstract][Full Text] [Related]
9. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
[TBL] [Abstract][Full Text] [Related]
10. Systemic transcriptome analysis of hepatocellular carcinoma.
Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
[TBL] [Abstract][Full Text] [Related]
12. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma.
Chen J; Liu W; Du J; Wang P; Wang J; Ye K
Front Genet; 2021; 12():778095. PubMed ID: 35222516
[No Abstract] [Full Text] [Related]
14. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
[TBL] [Abstract][Full Text] [Related]
15. Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma.
Gao F; Xia Y; Wang J; Lin Z; Ou Y; Liu X; Liu W; Zhou B; Luo H; Zhou B; Wen B; Zhang X; Huang J
Genome Biol; 2014 Dec; 15(12):533. PubMed ID: 25517360
[TBL] [Abstract][Full Text] [Related]
16. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics Analysis of Primary Cell Culture Models Reveals Genetic and Epigenetic Basis of Intratumoral Phenotypic Diversity.
Liu S; Yang Z; Li G; Li C; Luo Y; Gong Q; Wu X; Li T; Zhang Z; Xing B; Xu X; Lu X
Genomics Proteomics Bioinformatics; 2019 Dec; 17(6):576-589. PubMed ID: 32205176
[TBL] [Abstract][Full Text] [Related]
18. Unique genomic profile of fibrolamellar hepatocellular carcinoma.
Cornella H; Alsinet C; Sayols S; Zhang Z; Hao K; Cabellos L; Hoshida Y; Villanueva A; Thung S; Ward SC; Rodriguez-Carunchio L; Vila-Casadesús M; Imbeaud S; Lachenmayer A; Quaglia A; Nagorney DM; Minguez B; Carrilho F; Roberts LR; Waxman S; Mazzaferro V; Schwartz M; Esteller M; Heaton ND; Zucman-Rossi J; Llovet JM
Gastroenterology; 2015 Apr; 148(4):806-18.e10. PubMed ID: 25557953
[TBL] [Abstract][Full Text] [Related]
19. Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma.
Yu D; Zhang G; Huang X; Wu C; Tan W; Qiao Y; Chang J; Zhao H; Bi X; Cai J; Li Y; Lin D
PLoS One; 2015; 10(5):e0126836. PubMed ID: 25965583
[TBL] [Abstract][Full Text] [Related]
20. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
